Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux
NCT ID: NCT01829074
Last Updated: 2013-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2013-04-30
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Usually, a doctor will prescribe medication for reflux based on the symptoms a patient complains of. Sometimes it works and the patient gets better, sometimes it does not work and the patient's condition does not improve. The doctor will also use findings from an examination with an endoscope in the patient's throat to see if there is any damage that might have been caused by reflux. One new device that doctors use to help them diagnose reflux has a sensor on the end of a tube that goes through the nose and rests in the throat. This sensor measures the acid reflux for 24 hours, showing the doctor when acid reflux occurs.
The study doctors are performing this research study to help them understand more about acid reflux disease, and the best ways to diagnose and treat their patients who have acid reflux.
The study involves procedures, medications and devices that are already used regularly in doctors' offices and hospitals. The experimental part of this research is blinding the study doctor to the results of the pH study until the end of a three month course of antireflux medication, and performing a second pH study to measure change in acid exposure.
Hypothesis: The Restech pH study helps identify patients who will respond positively to acid inhibitory therapy, and patients whose study normalizes will have better Symptomatic response rates than those whose pH levels fail to normalize.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
NCT06495606
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047
24 Hour Esophageal and Electrogastrography to Investigate the Mechanism of Reflux Esophagitis
NCT00154570
Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease
NCT00260572
Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR
NCT01755221
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Laryngoscopic examination performed on day of enrollment
* Indications present for a 24 hour oropharyngeal pH study (Restech)
* Indication to begin a 3 month course of antireflux therapy (Figure 1) based on symptom presentation and widely accepted otolaryngologic findings
* Willing to return to clinic in 3 months for follow up pH study
* Willing to participate in weekly phone calls with the study investigator to discuss compliance with medication and lifestyle modifications.
Exclusion Criteria
* Any subjects with significant medical conditions that, in the investigator's judgment, would compromise the subject's health and safety.
* Subjects who have undergone previous antireflux surgery
* Subjects treated for reflux, either with Proton Pump Inhibitors (PPI's) or H2RAs in the past 4 weeks
* Subjects previously treated for reflux, either with antireflux medication or surgery
* Subjects with alternative work schedules affecting nighttime sleep periods (i.e. nighttime shift employees)
* Subjects with conditions that contraindicate use of PPIs, as listed on product labeling.
* Women who are pregnant, or nursing.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Respiratory Technology Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nimish Vakil, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison, USA
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13RT001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.